secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K
Filed at:   2022-11-02T23:59:59+00:00
Accession:  0001564590-22-036358
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STAAR Surgical Q3 net sales $76M (+30% YoY); ICL units +40%; guides FY22 ~$285M
-------------------------------------------------------------------------------

- Net sales $76.0M, constant currency $80.0M (+37%); ICL sales $72.0M (+33%), ICL units +40%.
- GAAP EPS $0.21, adjusted EPS $0.37 vs. $0.12 and $0.21 in prior year quarter.
- Gross margin 79.5% vs 77.6%; operating expenses $46.8M vs $37.5M.
- FY22 net sales guided to ~$285M (~$300M constant currency); ICL sales ~$272M (+28% YoY).
- Other Products to be phased out by end-2023; FY23 net sales target ~$355M with 30% ICL growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000156459022036358/0001564590-22-036358-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000156459022036358/staa-8k_20221102.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-036358

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer